eXoZymes Inc. (EXOZ) vs Xilio Therapeutics, Inc. (XLO)
eXoZymes Inc. and Xilio Therapeutics, Inc. are both Biotechnology companies. eXoZymes Inc. and Xilio Therapeutics, Inc. are of similar size ($59.2M and $57.6M). eXoZymes Inc. has the higher net margin (0.00% vs −34.1%) and the higher return on invested capital (0.00% vs 0.00%). Across the 12 metrics below, Xilio Therapeutics, Inc. leads on 7 and eXoZymes Inc. on 5.
Valuation
Profitability
| Metric | EXOZ | XLO | Biotechnology median |
|---|---|---|---|
| Gross margin | — | 100.00% | 65.16% |
| Operating margin | 0.00% | (48.94%) | 0.00% |
| Net margin | 0.00% | (34.06%) | 0.00% |
| Free cash flow margin | 0.00% | (95.59%) | 0.00% |
| Return on equity | (187.16%) | (55.03%) | (57.72%) |
| Return on assets | (115.42%) | (15.16%) | (49.22%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack